Evaluation of tumor angiogenesis with a second-generation US contrast medium in a rat breast tumor model

Korean Journal of Radiology

Volumn 9, Issue 3, 2008, Pages 243-249

  Eun, Young Ko ^a   Sang, Hoon Lee ^b   Hak, Hee Kim ^b   Sung, Moon Kim ^b   Myung, Jin Shin ^b   Kim, Namkug ^b   Gong, Gyungyub ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Breast neoplasms; Breast, US; Contrast media; Experimental study

Indexed keywords

CONTRAST MEDIUM; ETHYLNITROSOUREA;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; ECHOGRAPHY; EXPERIMENTAL NEOPLASM; FEMALE; HEMODYNAMICS; IMAGE ENHANCEMENT; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CONTRAST MEDIA; ETHYLNITROSOUREA; FEMALE; HEMODYNAMICS; IMAGE ENHANCEMENT; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 46849102380     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2008.9.3.243     Document Type: Article

References (38)

1. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887
2. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-761
3. Toi M, Bando H, Kuroi K. The predictive value of angiogenesis for adjuvant therapy in breast cancer. Breast Cancer 2007;7:311-314
4. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Garrido L. Breast cancer: regional blood flow and blood volume measured with magnetic susceptibility-based MR imaging - initial results. Radiology 2002;223:558-565
5. Brix G, Kiessling F, Lucht R, Darai S, Wasser K, Delorme S, et al. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med 2004;52:420-429
6. Teifke A, Behr O, Schmidt M, Victor A, Vomweg TW, Thelen M, et al. Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. Radiology 2006;239:351-360
7. Frouge C, Guinebretiere JM, Contesso G, Di Paola R, Blery M. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994;29:1043-1049
8. Esserman L, Hylton N, George T, Weidner N. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 1999;5:13-21
9. Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996;200:639-649
10. Buckley DL, Drew PJ, Mussurakis S, Monson JR, Horsman A. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging 1997;7:461-464
11. Hulka CA, Edmister WB, Smith BL, Tan L, Sgroi DC, Campbell T, et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 1997;205:837-842
12. Su MY, Wang Z, Carpenter PM, Lao X, Muhler A, Nalcioglu O. Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents. J Magn Reson Imaging 1999;9:177-186
13. Thompson HK Jr, Starmer CF, Whalen RE, McIntosh HD. Indicator transit time considered as a gamma variate. Circ Res 1964;14:502-515
14. Wilke N, Simm C, Zhang J, Ellermann J, Ya X, Merkle H, et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 1993;29:485-497
15. Wilke N, Jerosch-Herold M, Stillman AE, Kroll K, Tsekos N, Merkle H, et al. Concepts of myocardial perfusion imaging in magnetic resonance imaging. Magn Reson Q 1994;10:249-286
16. Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH. Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 2005;97:172-187
17. Less JR, Skalak TC, Sevick EM, Jain RK. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 1991;51:265-273
18. Peters-Engl C, Medl M, Mirau M, Wanner C, Bilgi S, Sevelda P, et al. Color-coded and spectral Doppler flow in breast carcinomas - relationship with the tumor microvasculature. Breast Cancer Res Treat 1998;47:83-89
19. Kim EA, Yoon KH, Lee YH, Kim HW, Juhng SK, Won JJ. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent. Korean J Radiol 2003;4:224-233
20. Yamaguchi A, Hayashi Y, Kojima Y, Miyagawa H, Ito M, Kohri K. Testicular torsion: usefulness of contrast-enhanced power Doppler sonography. Int J Urol 2005;12:849-851
21. Tani T, Tanabe K, Tani M, Ono F, Katayama M, Tamita K, et al. Quantitative assessment of harmonic power doppler myocardial perfusion imaging with intravenous Levovist in patients with myocardial infarction: comparison with myocardial viability evaluated by coronary flow reserve and coronary flow pattern of infarct-related artery. Cardiovasc Ultrasound 2005;3:22
22. Greis C. Technology overview: SonoVue (Bracco, Milan). Eur Radiol 2004;14 Suppl 8:P11-15
23. Schneider M, Arditi M, Barrau MB, Brochot J, Broillet A, Ventrone R, et al. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 1995;30:451-457
24. Lim A, Cosgrove D. Functional studies. Eur Radiol 2004;14 Suppl 8:P110-115
25. Bokor D. Diagnostic efficacy of SonoVue. Am J Cardiol 2000;86:19G-24G
26. Ding H, Wang WP, Huang BJ, Wei RX, He NA, Qi Q, et al. Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med 2005;24:285-297
27. Rosen L. Antiangiogenic strategies and agents in clinical trials. Oncologist 2000;5:20-27
28. Davis DW, McConkey DJ, Abbruzzese JL, Herbst RS. Surrogate markers in antiangiogenesis clinical trials. Br J Cancer 2003;89:8-14
29. Anderson H, Price P, Blomley M, Leach MO, Workman P. Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques. Br J Cancer 2001;85:1085-1093
30. Turetschek K, Preda A, Novikov V, Brasch RC, Weinmann HJ, Wunderbaldinger P, et al. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights. J Magn Reson Imaging 2004;20:138-144
31. Kuhl CK, Bieling H, Gieseke J, Ebel T, Mielcarek P, Far F, et al. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging. Radiology 1997;202:87-95
32. Mussurakis S, Buckley DL, Horsman A. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology 1997;203:317-321
33. Szabo BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Bone B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003;13:2425-2435
34. Stomper PC, Herman S, Klippenstein DL, Winston JS, Budnick RM, Stewart CC. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage. Cancer 1996;77:1844-1849
35. Kvistad KA, Lundgren S, Fjosne HE, Smenes E, Smethurst HB, Haraldseth O. Differentiating benign and malignant breast lesions with T2*-weighted first pass perfusion imaging. Acta Radiol 1999;40:45-51
36. Cosgrove D. Future prospects for SonoVue and CPS. Eur Radiol 2004;14 Suppl 8:P116-124
37. Tang MX, Eckersley RJ, Noble JA. Pressure-dependent attenuation with microbubbles at low mechanical index. Ultrasound Med Biol 2005;31:377-384
38. Chen Q, Zagzebski J, Wilson T, Stiles T. Pressure-dependent attenuation in ultrasound contrast agents. Ultrasound Med Biol 2002;28:1041-1051